(secondQuint)Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants.

 The subjects are randomized to 2 study groups.

 Group 1 receives standard chemotherapy prescribed by the cancer doctor (carboplatin and paclitaxel)with a possible choice to extend chemotherapy for up to an additional 12 months.

 Group 2 receives standard chemotherapy in the same manner as group 1.

 In addition, they receive 12 months of oral or IV nutritional supplements.

.

 Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants@highlight

The purpose of this study is to try and understand if there is added benefit or increased harm when antioxidant nutritional supplements are added to traditional chemotherapy in the treatment of ovarian cancer.

